OPTIMI HEALTH CORP. (F:8BN) — Market Cap & Net Worth
Market Cap & Net Worth: OPTIMI HEALTH CORP. (8BN)
OPTIMI HEALTH CORP. (F:8BN) has a market capitalization of $18.39 Million (€15.73 Million) as of August 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #25334 globally and #2177 in its home market, demonstrating a 1616.98% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying OPTIMI HEALTH CORP.'s stock price €3.64 by its total outstanding shares 96776919 (96.78 Million). Review OPTIMI HEALTH CORP. total liabilities to assess the company's total debt and financial obligations.
OPTIMI HEALTH CORP. Market Cap History: 2021 to 2026
OPTIMI HEALTH CORP.'s market capitalization history from 2021 to 2026. Data shows growth from $36.54 Million to $411.84 Million (46.69% CAGR).
OPTIMI HEALTH CORP. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how OPTIMI HEALTH CORP.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
52.55x
OPTIMI HEALTH CORP.'s market cap is 52.55 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $18.31 Million | $80.72K | -$7.35 Million | 226.80x | N/A |
| 2023 | $12.90 Million | $181.09K | -$5.19 Million | 71.23x | N/A |
| 2024 | $16.29 Million | $389.85K | -$6.04 Million | 41.79x | N/A |
| 2025 | $22.40 Million | $426.30K | -$3.71 Million | 52.55x | N/A |
Competitor Companies of 8BN by Market Capitalization
Companies near OPTIMI HEALTH CORP. in the global market cap rankings as of August 5, 2026.
Key companies related to OPTIMI HEALTH CORP. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #504 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #543 globally with a market cap of $49.47 Billion USD ( CN¥338.09 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #549 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #504 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #543 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $49.47 Billion | CN¥53.00 |
| #549 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.97 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.70 |
OPTIMI HEALTH CORP. Historical Marketcap From 2021 to 2026
Between 2021 and today, OPTIMI HEALTH CORP.'s market cap moved from $36.54 Million to $ 411.84 Million, with a yearly change of 46.69%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €411.84 Million | +1738.38% |
| 2025 | €22.40 Million | +37.50% |
| 2024 | €16.29 Million | +26.32% |
| 2023 | €12.90 Million | -29.54% |
| 2022 | €18.31 Million | -49.91% |
| 2021 | €36.54 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of OPTIMI HEALTH CORP. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.39 Million USD |
| MoneyControl | $18.39 Million USD |
| MarketWatch | $18.39 Million USD |
| marketcap.company | $18.39 Million USD |
| Reuters | $18.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About OPTIMI HEALTH CORP.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and… Read more